ESMO 2010 Society Booths

AIOM, Associazione Italiana di Oncologia Medica 

The Italian Association of Medical Oncology was established in 1973. AIOM’s purpose is to bring together specialists in Medical Oncology and to promote progress in the clinical, experimental and social welfare fields, experimental and clinical research, primary prevention, secondary prevention, the quality of oncological treatments, therapeutic continuity by means of guidelines for anti-cancer medical therapy, interdisciplinary activities, rehabilitation, etc. 

ASCO, American Society of Clinical Oncology

The American Society of Clinical Oncology (ASCO) is the world’s leading professional society of multidisciplinary medical professionals who treat people with cancer. ASCO members, from the U.S. and abroad, set the standard for patient care worldwide in the fight for more effective cancer treatments. ASCO membership is comprised of over 28,000 oncology professionals. 

BDA, Biotherapy Development Association

The Biotherapy Development Association (BDA), a non-profit organisation under German law, is a global cooperative group whose primary focus is to develop targeted cancer therapies using biological agents. Furthermore BDA provides an effective interface with regulatory authorities and gives advice on the development of biotherapies. It is based in Europe and interacts with the US, Japan and South-east Asia.

BIG, Breast International Group

The Breast International Group (BIG)-aisbl is a non-profit organisation for academic breast cancer research groups from around the world, based in Brussels, Belgium. BIG facilitates breast cancer research at international level by stimulating cooperation between its members and other academic networks, and collaborating with, but working independently from, the pharmaceutical industry. 

CSCO, Chinese Society of Clinical Oncology

Founded on 28 April 1997 in Beijing, Chinese Society of Clinical Oncology (CSCO) is a non-profit academic organisation. In accordance with the tenet, 'Teamwork, Cooperation and Practicality', CSCO has substantially contributed to accelerating the development of clinical oncology. By the end of December 2009, CSCO counted over 8,300 individual members and 70 international or domestic pharmaceutical enterprises as group members.

EANO, European Association of Neuro-Oncology

EANO is the pan-European organisation that represents all the medical and scientific disciplines involved in the diagnosis and treatment of tumours of the nervous system. EANO exists to stimulate interaction and collaboration between those with an interest in neurooncology and provides educational activities through events such as the biennial EANO congresses and also via the EANO website.


ecancermedicalscience is the free, peer-reviewed, open access journal from the European Institute of Oncology. Targeted at cancer professionals, ecancer publishes new, innovative research along with multimedia extras including video interviews with key oncology experts, news and blogs. ecancer is not for profit and aims to improve communication between sub-specialised cancer scientists and clinicians by working smarter and faster. 

ECCO, the European CanCer Organisation

Following the philosophy that every cancer patient deserves the best, ECCO focuses on creating awareness of patients’ needs and wishes, stimulating progressive thinking in Cancer policy, training and education, and encouraging European cancer research and its application through the organisation of international multidisciplinary conferences including the premier European cancer meetings: the ECCO – ESMO Multidisciplinary Cancer Congresses. 

ESMO, European Society for Medical Oncology

The European Society for Medical Oncology (ESMO) is the leading European professional organisation, committed to advancing the speciality of medical oncology and promoting a multidisciplinary approach to cancer treatment and care. Since its foundation in 1975 as a non-profit organisation, ESMO’s mission has been to advance cancer care and cure. We achieve this through fostering and disseminating good science that leads to better medicine and determines best practice. In this way ESMO fulfils its goal to support oncology professionals in providing people with cancer with the most effective treatments available and the high-quality care they deserve. The myESMO community is a powerful alliance of more than 6,000 committed oncology professionals from over 100 countries. As a trusted organisation with 35 years of experience and over 500 expert committee members, ESMO serves its members and the oncology community through:

  • excellence in post-graduate oncology education and training
  • leadership in transforming evidence-based research into standards of cancer care in Europe
  • dedicated efforts to foster a more favourable environment for scientific research
  • innovative international platforms to share expertise, best practices and disseminate the most up-to-date scientific research to as wide an audience as possible.

ESMO’s scientific journal, Annals of Oncology, ranks among the top clinical oncology journals worldwide. ESMO events are the meeting place in Europe for medical oncologists to update their knowledge, network and exchange ideas. ESMO also unites key oncology stakeholders and forges strategic partnerships to address critical issues related to the profession and practice of medical oncology. Recognised as an authoritative voice in the fight against cancer, ESMO is pleased to offer consultative expertise to oncology organisations and European authorities on important issues related to cancer research, prevention, diagnosis, treatment and care.

EORTC, European Organisation for Research and Treatment of Cancer

The aims of the EORTC are to develop, conduct, coordinate, and stimulate translational and clinical research in Europe to improve the management of cancer and related problems by increasing survival and patient quality of life. The ultimate goal of the EORTC is to improve the standard of care through research within the EORTC network of more than 300 hospitals. More information about the EORTC can be found on our website:

ESO, European School of Oncology

The European School of Oncology (ESO) was founded in 1982 with the aim of contributing to the reduction of deaths from cancer due to late diagnosis and/or inadequate treatment. ESO’s mission is reflected in its motto “Learning to Care”, which stresses the concept of studying and learning and also of caring for the patient in a global sense.


Founded in 1980, ESTRO, the European Society for Therapeutic Radiology and Oncology, represents all professionals involved in the management of cancer patients and using radiotherapy in Europe. With close to 5000 members, the society promotes the international exchange and dissemination of scientific information, organises conferences, and provides educational courses and materials, supporting then the role of radiation oncology in the multimodality treatment of cancer. 

MASCC, Multinational Association of Supportive Care in Cancer


MASCC is an international, multidisciplinary organisation that operates in collaboration ISOO. MASCC’s core purpose is to promote optimal supportive care - the prevention and management of the adverse effects of cancer and its treatment. For further information, see our website, 

NDDO Education Foundation

The NDDO Education Foundation’s aim is to disseminate findings from experimental and clinical studies on prevention and treatment of life-threatening and/or invalidating diseases such as cancer. The Foundation is the founder and primary organiser of the “International Symposium on Targeted Anticancer Therapies” (TAT) and an international expert forum on “Methodology for the Development of Innovative Cancer Therapies” (MDICT).

OECI, Organisation of European Cancer Institutes

Established in 1977 to promote cooperation among EU cancer centres and institutes, in 2005 the Organisation was remodelled into a European Economic Interest Grouping.

OECI is a continuously growing network, grouping 73 members, working in crosscut expertise projects within its Working Groups (Accreditation and Designation; Education and Training, Molecular Pathobiology and Cancer Biobanks) and Activities (START Project and WIN Consortium). 

SIOG, International Society of Geriatric Oncology

SIOG is an international society open to oncology specialists, geriatricians and other interested health care professionals.

Its main objectives are:

  • Improving research in the field of geriatric oncology
  • Promoting education of physicians and other healthcare professionals in geriatric oncology
  • Achieving a high common standard of care for elderly cancer patients

SIOG’s new official journal is the just launched Journal of Geriatric Oncology, published by Elsevier. 

SONK, St. Gallen Oncology Conferences

Conferences (SONK) is a private charitable foundation. It organises repeatedly international breast cancer conferences, which includes the St.Gallen breast cancer treatment consensus meeting (next 16-19 March 2011). SONK is also the coordination secretariat of the German-speaking DESO-group and designs the programme with some 14 seminars about clinical oncology, nursing oncology and palliative care.